Phillip Vanlandingham
- Molecular Biology
- Cell Biology top 10%
- Epidemiology
- Physiology
- Physiology top 5%
- Co-authors
- Brian P. CeresaBing ZhangNoreen E. ReistHong BaoSuzanne M. RoyerRafal FarjoAlexander B. QuiambaoKrysten M. Farjo
- Topics
- Retinal Development and Disorders (3 papers)Cellular transport and secretion (3 papers)Erythrocyte Function and Pathophysiology (2 papers)
- Cited by
- PhysiologyCell BiologyAging
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- United StatesEthiopiaSouth Korea
In The Last Decade
Phillip Vanlandingham
7 papers receiving 480 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 290
- Cell Biology 182
- Epidemiology 75
- Physiology 60
- Physiology 53
Countries citing papers authored by Phillip Vanlandingham
This map shows the geographic impact of Phillip Vanlandingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Vanlandingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Vanlandingham more than expected).
Fields of papers citing papers by Phillip Vanlandingham
This network shows the impact of papers produced by Phillip Vanlandingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Vanlandingham. The network helps show where Phillip Vanlandingham may publish in the future.
Co-authorship network of co-authors of Phillip Vanlandingham
This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Vanlandingham. A scholar is included among the top collaborators of Phillip Vanlandingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Vanlandingham. Phillip Vanlandingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 14 | |
| 4 | 29 | |
| 5 | 31 | |
| 6 | Eyedrop application of CLT-005, a Stat3 inhibitor, is efficacious in animal models of Wet and Dry Age-related Macular Degeneration | 1 |
| 7 | 14 | |
| 8 | 48 | |
| 9 | 337 | |
| 10 | 11 |
About Phillip Vanlandingham
Phillip Vanlandingham is a scholar working on Cell Biology, Ophthalmology and Cellular and Molecular Neuroscience, having authored 10 papers that have together received 485 indexed citations. Recurring topics across this work include Retinal Development and Disorders (3 papers), Cellular transport and secretion (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Physiology (53 citations), Cell Biology (182 citations) and Aging (8 citations). Phillip Vanlandingham has collaborated with scholars based in United States, Ethiopia and South Korea. Frequent co-authors include Brian P. Ceresa, Bing Zhang, Noreen E. Reist, Hong Bao, Suzanne M. Royer, Bing Zhang, Rafal Farjo, Alexander B. Quiambao, Krysten M. Farjo and Gennadiy Moiseyev. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.